Fidelity Investments’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-23,640
| Closed | -$507K | – | 5606 |
|
|
2026
Q1 | $507K | Sell |
23,640
-5,693,368
| -100% | -$80.2M | ﹤0.01% | 3122 |
|
|
2025
Q4 | $53.3M | Sell |
5,717,008
-4,380,660
| -43% | -$36.6M | ﹤0.01% | 1415 |
|
|
2025
Q3 | $71.2M | Sell |
10,097,668
-1,245,031
| -11% | -$8.57M | ﹤0.01% | 1310 |
|
|
2025
Q2 | $73.7M | Sell |
11,342,699
-2,357,749
| -17% | -$16.2M | ﹤0.01% | 1241 |
|
|
2025
Q1 | $109M | Buy |
13,700,448
+812,981
| +6% | +$8.76M | 0.01% | 1060 |
|
|
2024
Q4 | $163M | Buy |
12,887,467
+5,475,087
| +74% | +$76.2M | 0.01% | 901 |
|
|
2024
Q3 | $103M | Buy |
7,412,380
+4,750,936
| +179% | +$67.8M | 0.01% | 1085 |
|
|
2024
Q2 | $36.7M | Sell |
2,661,444
-1,742,897
| -40% | -$25.5M | ﹤0.01% | 1434 |
|
|
2024
Q1 | $72.8M | Buy |
4,404,341
+436,175
| +11% | +$6.53M | ﹤0.01% | 1183 |
|
|
2023
Q4 | $57.9M | Sell |
3,968,166
-2,057,962
| -34% | -$24.9M | ﹤0.01% | 1232 |
|
|
2023
Q3 | $73.9M | Sell |
6,026,128
-1,533,775
| -20% | -$20M | 0.01% | 1097 |
|
|
2023
Q2 | $90.3M | Sell |
7,559,903
-1,012,280
| -12% | -$13.2M | 0.01% | 1040 |
|
|
2023
Q1 | $115M | Sell |
8,572,183
-430,128
| -5% | -$8.4M | 0.01% | 936 |
|
|
2022
Q4 | $194M | Buy |
9,002,311
+210,820
| +2% | +$4.32M | 0.02% | 698 |
|
|
2022
Q3 | $176M | Buy |
8,791,491
+1,964,917
| +29% | +$41.8M | 0.02% | 723 |
|
|
2022
Q2 | $122M | Buy |
6,826,574
+4,232,055
| +163% | +$43.7M | 0.01% | 890 |
|
|
2022
Q1 | $25.7M | Sell |
2,594,519
-235,834
| -8% | -$3.12M | ﹤0.01% | 1673 |
|
|
2021
Q4 | $47.7M | Buy |
2,830,353
+668,444
| +31% | +$13.7M | ﹤0.01% | 1438 |
|
|
2021
Q3 | $51.3M | Sell |
2,161,909
-150,541
| -7% | -$3.61M | ﹤0.01% | 1399 |
|
|
2021
Q2 | $52.7M | Buy |
+2,312,450
| New | +$48.2M | ﹤0.01% | 1400 |
|
Other funds holding DAWN
Fidelity Investments's DAWN Position: Q2 2026 in Review
Fidelity Investments sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 23,640 shares — an estimated $507K sold.
Fidelity Investments first reported a position in DAWN in Q2 2021 and held it in 20 quarters. The position peaked at $194M in Q4 2022. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- Fidelity Investments reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Fidelity Investments sold 23,640 Day One Biopharmaceuticals shares in Q2 2026, an estimated $507K.
- Fidelity Investments first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 20 quarters.
- Fidelity Investments's Day One Biopharmaceuticals position peaked at $194M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.